Quick Answer: CPNP, CPSR and PIF are three different parts of EU cosmetic compliance. CPNP is the EU online notification portal; a CPSR is the qualified safety report for the finished product; and the PIF is the broader product dossier that contains the CPSR and other required records. The EU Responsible Person must ensure the safety assessment and PIF are ready, and submit the required CPNP information before the cosmetic is placed on the EU market.
Last reviewed: 27 September 2026. Editorial review: MOOYAM cosmetic compliance content team. This comparison is written for international brand owners, importers, distributors and contract manufacturers; it is general information, not product-specific legal advice.
The three terms at a glance
Regulation (EC) No 1223/2009 connects these requirements but does not make them interchangeable. Article 10 and Annex I address the cosmetic product safety assessment and report; Article 11 addresses the Product Information File; Article 13 addresses notification through the Cosmetic Products Notification Portal. An EU-established Responsible Person (RP) is the compliance anchor under Article 4. The current Regulation text should be consulted for the exact obligations applying to a product.
| Term | What it is | Main legal anchor | What it does not mean |
|---|---|---|---|
| CPNP | Free EU online cosmetic product notification system | Article 13 | Government approval or substitute for safety records |
| CPSR | Qualified assessment and report on the safety of the finished cosmetic | Article 10 and Annex I | A generic factory certificate or marketing test |
| PIF | Controlled product dossier held accessible by the RP | Article 11 | A single certificate or only the CPNP submission |
What is CPNP—and what does notification accomplish?
The European Commission describes CPNP as a free online notification system. Under Article 13, the RP—and certain distributors in specified circumstances—submit prescribed information before the product is placed on the EU market. The portal makes information available electronically to competent authorities for market surveillance and to poison centres or similar bodies for medical treatment purposes. After a product is notified in CPNP, the Commission says no further national notification is needed within the EU.
Notification is not an authority’s safety endorsement. A brand must not treat a portal submission or number as proof that a claim is approved, a formula is safe, or a PIF is complete. Product changes may require an update to notified information, so the RP should keep the CPNP record aligned with the final formula, product category, label and market presentation.
What is a CPSR—and who can complete it?
The Cosmetic Product Safety Report is the documented result of the safety assessment required before market placement. Annex I distinguishes Part A, which assembles the necessary safety information, from Part B, which gives the safety conclusion, warnings or instructions, reasoning and assessor details. Article 10 specifies the required qualifications for the person performing the assessment. A factory can gather technical inputs, but ordinary manufacturing records alone are not the qualified assessor’s Part B judgement.
Commission Implementing Decision 2013/674/EU gives guidance on Annex I. It explains that Part A should enable assessment of the product’s risks and Part B should transparently reason from the data to a safety conclusion. The RP must ensure the report stays current in light of relevant new information. There is no universal fixed “CPSR expiry date” or one mandatory test package for every cosmetic.
What belongs in the PIF?
Article 11 requires a PIF for each cosmetic product. It includes a product description, the CPSR, a description of manufacturing method and a statement of good-manufacturing-practice compliance, proof of the claimed effect where justified by the claim’s nature or effect, and information on animal testing where relevant. The PIF must be kept readily accessible to competent authorities at the RP address indicated on the label and retained for ten years after the last batch of the product was placed on the market.
The PIF is therefore a maintained record system, not merely a PDF template. The EU Cosmetics Regulation overview explains its place in the broader launch sequence. A CPSR sits inside the PIF, but the PIF has additional elements. CPNP is separate: the portal receives the prescribed notification data, not a replacement for an accessible PIF.
| Party | CPNP role | CPSR role | PIF role |
|---|---|---|---|
| EU Responsible Person | Ensures required Article 13 submission before market placement | Ensures qualified assessment and current report | Keeps required dossier accessible and current |
| Qualified safety assessor | May advise on product data but is not inherently the notifier | Assesses final product and signs the safety conclusion | Provides the safety report and referenced basis |
| Brand owner or importer | Supplies product, label and market data; confirms RP arrangement | Provides intended use, claims and product changes | Controls final artwork, claims and commercial versions |
| OEM/ODM manufacturer | Provides accurate product identity and formula data to RP | Supplies formula, quality, test and packaging inputs | Provides manufacturing method, GMP statement and supporting records |
A practical order of work before EU launch
First, confirm that the item is a cosmetic under the Regulation and appoint an EU RP. Second, freeze the intended formula, packaging, user group and claims. Third, give the qualified assessor reliable final-product information and resolve safety questions. Fourth, complete the CPSR and assemble the broader PIF. Fifth, review ingredients, label and claims against the same controlled product version. Sixth, submit the required CPNP notification before market placement. Seventh, release only the approved commercial version and maintain update procedures.
The steps may overlap operationally, but a CPNP submission cannot compensate for an unfinished CPSR or PIF. Likewise, a completed dossier does not remove the Article 13 notification duty. A checklist signed by the brand, RP, assessor and manufacturer helps avoid the common situation where each party assumes another has completed the final step.
For a separate treatment of the notification workflow, see the site’s EU market-entry guide. Ingredient controls should be screened through the EU ingredient-check workflow, and product claims through the EU claims guide. These are linked compliance checks, not documents that substitute for one another.
Common mix-ups for international brands
“We have a CPNP number, so the product is approved” is incorrect: notification does not mean EU approval. “The lab issued a CPSR, so the PIF is complete” is also incomplete: the PIF includes other records. “The factory gave us a GMP certificate, so the CPSR is unnecessary” confuses manufacturing controls with product-specific safety assessment. Finally, a generic dossier for a different SKU, fragrance variant or old formula must not be assumed to cover the product actually marketed.
FAQ
Is the CPSR part of the PIF?
Yes. The CPSR is a central safety element of the broader Article 11 PIF; the PIF includes additional product, manufacturing and, where applicable, claims records.
Does CPNP approve a cosmetic product?
No. CPNP is an information-notification system, not a pre-market approval service or a safety assessment.
Can a non-EU manufacturer submit the CPNP notification?
The RP is responsible for the Article 13 obligation, with distributor duties in specified cases. A non-EU manufacturer can supply data or act through authorized arrangements, but should not assume it replaces the EU RP.
Must the entire PIF be uploaded to CPNP?
No. The Regulation distinguishes the notification information submitted through CPNP from the PIF kept readily accessible at the RP address.
Which should be completed first?
Have the safety assessment and PIF ready for the finished product, then ensure the required notification is submitted before placing it on the EU market. Plan all three together.
Official sources
Regulation (EC) No 1223/2009, Articles 4 and 10–13 and Annex I; European Commission CPNP page; Commission Implementing Decision 2013/674/EU, CPSR guidance; European Commission cosmetics legislation overview.
Manufacturer support: MOOYAM provides cosmetic OEM/ODM manufacturing and technical documentation support for international beauty brands. We can organize final formula, quality, testing, packaging and batch records for a brand’s RP and assessor; the RP and qualified assessor retain their respective legal and scientific responsibilities.
Regulatory requirements may change. Brands should verify current requirements with the relevant regulatory authority or a qualified compliance professional before placing cosmetic products on the market.